Bevacizumab 100mg Injection Bevazza

Trade Name: Bevazza

Manufacturer: Lupin Ltd

Presentation: Injection

Strength: 100mg

What is the purpose of Bevacizumab 100mg Injection Bevazza?

Bevacizumab 100mg Injection Bevazza In persons who have not previously taken chemotherapy, in conjunction with atezolizumab, to treat hepatocellular carcinoma (HCC) that has spread or cannot be removed by surgery.

Is Bevzumab 100mg Injection Bevazzaa a chemotherapeutic agent?

Bevacizumab 100mg Injection Bevazza Avastin isn’t a type of chemotherapy.) However, Avastin is allowed for treatment alone in some cancers. Bevacizumab is the active ingredient in Avastin. It’s a monoclonal antibody, a type of medicine derived from immune system cells.

Can Bevacizumab 100mg Injection Bevazza be used to treat cancer?

Bevacizumab 100mg Injection Bevazza Can Avastin be used to treat colon cancer? No, it isn’t. Avastin, on the other hand, greatly extends survival time. Patients who received Avastin along with chemotherapy such as 5-FU, leucovorin, oxaliplatin, and irinotecan lived roughly five months longer in clinical trials than those who had the chemotherapy alone.

What are the Bevacizumab 100mg Injection Bevazza side effects?

  • Consequences
  • Stools that are black and tarry.
  • aches and pains in the body
  • Hands, arms, foot, or legs burning, tingling, numbness, or pain
  • Pain, discomfort, or tightness in the chest.
  • urine that is hazy
  • abrasions on the skin
  • Urine output has decreased.
  • Breathing that is laborious or labored.

For more details Click Here.

When should you start taking bevacizumab?

Bevacizumab is a generic name for the drug bevacizumab.

This drug is an IgG1 (man-made antibody) that is used to treat a variety of cancers. This medicine works by inhibiting a specific protein (vascular endothelial growth factor-VEGF), which reduces the tumor’s blood supply and slows its growth.

What is the efficacy of bevacizumab?

In the bevacizumab alone and combination arms, six-month progression-free and overall survival rates were 43 percent and 50 percent, respectively, and 9.2 months and 8.7 months. The treatment was generally tolerated, with the most common side effects being hypertension, seizures, neutropenia, and weariness.

Bevacizumab is used to treat a variety of malignancies.

The monoclonal antibody is also approved for the treatment of lung cancer, kidney cancer, and glioblastoma, in addition to colorectal cancer. (For specific indicators, see the table below.) Bevacizumab has also been approved for the treatment of HER2-negative metastatic breast cancer.

We are a global wholesaler and exporter from India and operate in more than 5 countries like UAE, the United States Of America, Italy, New Zealand, Indonesia, etc. If you are looking for another product or brand click here.